FORTIS HEALTHCARE
Quarterly Results Analysis [Mar2025]
FORTIS HEALTHCARE Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2,007 Cr | ₹1,928 Cr | ₹1,988 Cr | ₹1,859 Cr | ₹1,786 Cr | ₹1,680 Cr | ₹1,770 Cr | ₹1,657 Cr |
Expenses | ₹1,572 Cr | ₹1,553 Cr | ₹1,554 Cr | ₹1,516 Cr | ₹1,405 Cr | ₹1,396 Cr | ₹1,440 Cr | ₹1,385 Cr |
Operating Income | ₹435 Cr | ₹375 Cr | ₹435 Cr | ₹343 Cr | ₹381 Cr | ₹284 Cr | ₹330 Cr | ₹272 Cr |
Other Income | ₹20 Cr | ₹21 Cr | ₹13 Cr | ₹13 Cr | ₹10 Cr | ₹7 Cr | ₹14 Cr | ₹8 Cr |
Interest | ₹68 Cr | ₹45 Cr | ₹36 Cr | ₹35 Cr | ₹35 Cr | ₹33 Cr | ₹32 Cr | ₹31 Cr |
Depreciation | ₹102 Cr | ₹97 Cr | ₹95 Cr | ₹91 Cr | ₹92 Cr | ₹87 Cr | ₹84 Cr | ₹79 Cr |
Profit Before Tax | ₹232 Cr | ₹277 Cr | ₹257 Cr | ₹229 Cr | ₹267 Cr | ₹179 Cr | ₹231 Cr | ₹171 Cr |
Profit After Tax | ₹183 Cr | ₹252 Cr | ₹189 Cr | ₹173 Cr | ₹199 Cr | ₹130 Cr | ₹183 Cr | ₹125 Cr |
EPS | ₹2.44 | ₹3.28 | ₹2.34 | ₹2.20 | ₹2.37 | ₹1.78 | ₹2.30 | ₹1.48 |
Industry Peers & Returns | 1W | 1M | 1Y |
FORTIS HEALTHCARE | -0.6% | 9.7% | 64.2% |
MAX HEALTHCARE INSTITUTE | 2.9% | 2.1% | 43.4% |
APOLLO HOSPITALS ENTERPRISE | 0.8% | 1.1% | 15.2% |
GLOBAL HEALTH | -2.6% | -4.6% | -2.6% |
NARAYANA HRUDAYALAYA | 3.9% | 2.4% | 44.9% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.1% | 3.3% | 76.6% |
DR LAL PATHLABS | 4.2% | 5.8% | 6.4% |
ASTER DM HEALTHCARE | -2.4% | -1.6% | 59% |
RAINBOW CHILDRENS MEDICARE | 3.1% | 5.7% | 6% |
FORTIS HEALTHCARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.09 % |
Y-o-Y | 12.39 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹2,007 Cr | 4.09 | |
Dec2024 | ₹1,928 Cr | -3.02 | |
Sep2024 | ₹1,988 Cr | 6.97 | |
Jun2024 | ₹1,859 Cr | 4.09 | |
Mar2024 | ₹1,786 Cr | 6.32 | |
Dec2023 | ₹1,680 Cr | -5.10 | |
Sep2023 | ₹1,770 Cr | 6.79 | |
Jun2023 | ₹1,657 Cr | - |
FORTIS HEALTHCARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 16.09 % |
Y-o-Y | 14.28 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹435 Cr | 16.09 | |
Dec2024 | ₹375 Cr | -13.73 | |
Sep2024 | ₹435 Cr | 26.95 | |
Jun2024 | ₹343 Cr | -10.11 | |
Mar2024 | ₹381 Cr | 34.18 | |
Dec2023 | ₹284 Cr | -13.99 | |
Sep2023 | ₹330 Cr | 21.18 | |
Jun2023 | ₹272 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.57 % |
Y-o-Y | 1.69 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 21.7% | 11.57 | |
Dec2024 | 19.45% | -11.07 | |
Sep2024 | 21.87% | 18.67 | |
Jun2024 | 18.43% | -13.64 | |
Mar2024 | 21.34% | 26.20 | |
Dec2023 | 16.91% | -9.33 | |
Sep2023 | 18.65% | 13.44 | |
Jun2023 | 16.44% | - |
FORTIS HEALTHCARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -27.30 % |
Y-o-Y | -7.77 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹183 Cr | -27.30 | |
Dec2024 | ₹252 Cr | 33.57 | |
Sep2024 | ₹189 Cr | 8.92 | |
Jun2024 | ₹173 Cr | -12.79 | |
Mar2024 | ₹199 Cr | 53.29 | |
Dec2023 | ₹130 Cr | -28.98 | |
Sep2023 | ₹183 Cr | 46.60 | |
Jun2023 | ₹125 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -30.12 % |
Y-o-Y | -17.88 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 9.14 % | -30.12 | |
Dec2024 | 13.08 % | 37.68 | |
Sep2024 | 9.5 % | 1.82 | |
Jun2024 | 9.33 % | -16.17 | |
Mar2024 | 11.13 % | 44.17 | |
Dec2023 | 7.72 % | -25.19 | |
Sep2023 | 10.32 % | 37.23 | |
Jun2023 | 7.52 % | - |
FORTIS HEALTHCARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -25.61 % |
Y-o-Y | 2.95 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹2.44 | -25.61 | |
Dec2024 | ₹3.28 | 40.17 | |
Sep2024 | ₹2.34 | 6.36 | |
Jun2024 | ₹2.2 | -7.17 | |
Mar2024 | ₹2.37 | 33.15 | |
Dec2023 | ₹1.78 | -22.61 | |
Sep2023 | ₹2.3 | 55.41 | |
Jun2023 | ₹1.48 | - |
You may also like the below Video Courses
MAX HEALTHCARE INSTITUTE LTD vs APOLLO HOSPITALS ENTERPRISE LTD vs FORTIS HEALTHCARE LTD
GLOBAL HEALTH LTD vs NARAYANA HRUDAYALAYA LTD vs KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD